Geoffrey Pilkington, Ryde, United Kingdom
Pilkington is Professor of Cellular and Molecular Neuro-oncology, and Head of the Brain Tumour Research Centre, University of Portsmouth [Previously, Professor of Experimental Neuro-oncology, Kings College, London]
He is Immediate Past President of the British Neuro-oncology Society, Executive Board Member and Treasurer of European Association of Neuro-Oncology and Founder and Co-ordinator of the South of England Brain Tumour Alliance. Geoff was formerly Programme Secretary, British Neuropathological Society and Committee Member. Geoff was also a Founder Member of EANO and BNOS.
Geoff was member of various national and international Advisory Boards of grant awarding bodies (e.g. CwCUK, Norwegian Research Council), reviewer for over 40 grant awarding bodies throughout the world, Editorial Board member of 5 international journals and reviewer for over 55 scientific journals. Examiner of over 30 PhD students (UK and overseas) and Supervisor of over 30 PhD students (London and Portsmouth)
Geoff is author of numerous publications on brain tumour biology, in particular development of in vitro and in vivo models of glioma, as well as investigations on the underlying mechanisms of brain tumour invasion. Currently he is involved with drug repurposing for glioblastoma and screening of delivery vehicles through a 3D all human model of the blood brain barrier.
Geoff has spent his entire career (Forty three years) in brain tumour research, having started work on chemical neuro-carcinogenesis where he studied brain cancer stem cells and brain tumour development at the Middlesex Hospital Medical School in the early 1970s and subsequently spent 23 years at the Institute of Psychiatry, King’s College, London, latterly as Professor of Experimental Neuro-oncology. In 2003 he moved to the School of Pharmacy & Biomedical Sciences, University of Portsmouth, as Professor of Cellular & Molecular Neuro-oncology & Director of Research.
Over the years the research focus of his group has been development of models for the study of intrinsic brain tumours, elucidation of the mechanisms underlying diffuse local invasive behaviour in glioma and development of novel strategies for mitochondrial mediation of apoptosis in glioma. Over the years Geoff has published numerous papers on the results of his research on human glioma and has developed various “all human” three-dimensional in vitro models to study brain tumour invasion and the blood-brain barrier.